Global ADME Toxicology Testing Markets, 2014-2018 & 2019-2025 - High Rate of Late Stage Drug Failure & Increasing Need for Novel Drug Molecules

World News: . []

Dublin, April 17, 2019 (GLOBE NEWSWIRE) -- The report has been added to offering. The global ADME toxicology testing market size is expected to generate a revenue of USD 10.25 billion by 2025, exhibiting a CAGR of 11.4% during the forecast period. Factors such as increased need to check late-stage drug failures with adoption of more appropriate toxicity testing methods by pharmaceutical companies is expected to aid revenue generation for the market.Absorption, distribution, metabolism, and excretion (ADME) toxicology testing is used to test toxic reactions caused by molecules in clinical trials on factors and systemic reactions such as chemical, pharmaceutical, and genetic. These toxicology testing procedures help in effective drug development, which limits or prevents toxic reactions to the body when administered. Toxicity levels are decided on the results of a series of tests conducted in near natural conditions, which represent almost real-time reactions between the drug and host.As of 2017, approximately 43.0% of ADME toxicology testing areas carried out are based on cell culture tech. Cell culture technology is adopted widely owing to advantages such as near natural conditions and accurate results obtained at a cellular level.These assays are conducted for several types of toxic reactions or systems where toxic reactions might take place. Some of the toxicity tests are systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and other toxicities that might result in a living tissue. Advancements in testing methods are underway and this trend is likely to be picked up by many companies developing drug molecules. This will speed up the drug discovery process and boost market growth.

For more information about this report visit

Research and Markets also offers services providing focused, comprehensive and tailored research.

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery

More news and information about Research and Markets

Published By:

Globe Newswire: 12:30 GMT Wednesday 17th April 2019

Published: .

Search for other references to "global" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us